These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3412988)

  • 21. Myocardial damage vis-a-vis plasma fibrinolytic activity and fibrinogen level--an experimental study.
    Saxena KK; Srivastava RK; Prasad DN
    Indian J Med Res; 1979 Aug; 70():263-7. PubMed ID: 521096
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):99-108. PubMed ID: 5074994
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood fibrinolytic activity in patients following myocardial infarct].
    Myśliwiec M; Bielawiec M; Perzanowski A
    Pol Tyg Lek; 1971 Dec; 26(49):1895-7. PubMed ID: 5156516
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
    Olszewski W; Laskowski S; Jeziorny J; Kogucki S
    Pol Tyg Lek; 1968 Dec; 23(49):1885-7. PubMed ID: 5704215
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction.
    Saxena KK; Gupta B; Gopal R; Srivastava SS; Singh RC; Kulshrestha VK; Prasad DN
    J Assoc Physicians India; 1986 Sep; 34(9):641-2. PubMed ID: 3793700
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of streptokinase on fibrinolysis in patients with acute myocardial infarction].
    Golikov AP; Zvereva TV; Platonova TK; Khvatov VB
    Klin Med (Mosk); 1984 Jan; 62(1):37-41. PubMed ID: 6708418
    [No Abstract]   [Full Text] [Related]  

  • 28. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levels of vascular plasminogen activator and its ability to be released into the blood in recent myocardial infarct].
    Psuja P
    Pol Arch Med Wewn; 1981 Apr; 65(4):295-303. PubMed ID: 7196570
    [No Abstract]   [Full Text] [Related]  

  • 30. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.
    Gram J; Jespersen J; Kluft C; Rijken DC
    Acta Med Scand; 1987; 221(2):149-53. PubMed ID: 3591453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction.
    Sharma SC; Seth HN
    Br Heart J; 1978 May; 40(5):526-9. PubMed ID: 656219
    [No Abstract]   [Full Text] [Related]  

  • 32. Defective fibrinolysis in survivors of myocardial infarction.
    Johnson O; Mellbring G; Nilsson T
    Int J Cardiol; 1984 Sep; 6(3):380-2. PubMed ID: 6541197
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood antiprotease activity and alpha-1-protease inhibitor level in patients with myocardial infarct].
    Orlov VN; Solod NN; Iunusov MA; Radzevich AE
    Kardiologiia; 1990 May; 30(5):64-6. PubMed ID: 2391814
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood lipid content and the coagulation system in coronary insufficiency in young persons].
    Uspenskaia VG
    Kardiologiia; 1973 Sep; 13(9):54-8. PubMed ID: 4775811
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibrinolysis and recurrence of myocardial infarction.
    Lancet; 1987 Aug; 2(8556):461-2. PubMed ID: 2887770
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proteolytic and antiproteolytic activity of the blood serum in myocardial infarct complications].
    Trofimov GA; Minin PP
    Kardiologiia; 1980 Jan; 20(1):99-101. PubMed ID: 6986503
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adhesion of platelets in vivo and fibrinolysis activation in patients with recent myocardial infarction].
    Malanowicz W; Zambrowicz K
    Pol Arch Med Wewn; 1968; 41(6):739-43. PubMed ID: 5707135
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of myocardial infarction. Procedures of important laboratory investigations.
    Lal HB; Caroli RK
    Indian J Med Res; 1968 Jul; 56(7 Suppl):1137-8. PubMed ID: 5724044
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Fibrinolysis in ischemic heart diseases (I)].
    Sasa H; Mizuguchi I; Futenma S; Ito K; Niwa T
    Jpn Circ J; 1975 Apr; 39(4):499. PubMed ID: 1121097
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spontaneous fibrinolysis in myocardial infarct].
    BELLI C; BATTISTONI L; GRIGOLATO V
    Minerva Med; 1962 Jan; 53():102-5. PubMed ID: 13866890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.